New study seeks to sharpen Alzheimer's diagnosis with simple tests
NCT ID NCT05020106
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find the best cutoff values for key Alzheimer's-related proteins in spinal fluid and blood to improve diagnostic accuracy. Researchers will compare results from Alzheimer's patients, those with mild memory problems, people with other dementias, and healthy older adults. The goal is to make diagnosis more reliable and earlier.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospital of Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100053, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your brain help unlock Alzheimer's secrets?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could a brain disease change behavior years before diagnosis?
- Skin, speech, and brain scans may unmask hidden neurodegeneration
- A scan that sees Alzheimer's tangles? trial puts tau tracer to the test